Francine Siegel, MD
Obstetrics & Gynecology · Willingboro, NJNPI 1285621078
Payments from drug & device makers
Across 63 payments — averaging $19.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$267
- Hologic Sales And Service, LLC$162
- Amgen$122
- AbbVie$114
- Astellas Pharma US Inc$106
- Mayne Pharma Commercial LLC$83
- plus $367 from 15 others
What the payments were for
- Food & beverage$1,222100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 10 | $267 |
| Hologic Sales And Service, LLC | 3 | $162 |
| Amgen | 9 | $122 |
| AbbVie | 8 | $114 |
| Astellas Pharma US Inc | 2 | $106 |
| Mayne Pharma Commercial LLC | 11 | $83 |
| Bayer | 3 | $61 |
| Shield Therapeutics Inc | 1 | $43 |
| Millicent US Inc | 2 | $32 |
| Vertical Pharmaceuticals, LLC | 2 | $28 |
| Tempus AI, Inc | 1 | $28 |
| Therapeuticsmd, Inc. | 2 | $27 |
| Astellas Pharma Global Development | 1 | $26 |
| Coopersurgical, Inc. | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Merck | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
| Mylan Pharmaceuticals Inc. | 1 | $14 |
| Organon | 1 | $14 |
| Duchesnay USA Incorporated | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Wegovy$115
- ACESSA PROVU SYSTEM$107
How this compares
$1,222 in reported general payments places this provider in the 65th percentile of 1,242 obstetrics & gynecology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 66 | $6,080 |
| PremarinEstrogens, Conjugated | 11 | $5,579 |
| YuvafemEstradiol | 15 | $2,891 |
| Risedronate Sodium | 24 | $2,429 |
| Clobetasol Propionate | 23 | $1,376 |
| Alendronate Sodium | 72 | $725 |
| Ibandronate Sodium | 11 | $566 |
| ValacyclovirValacyclovir Hcl | 19 | $277 |
| Fluconazole | 17 | $136 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Willingboro
- Jennifer AshtonEnglewood$1.5M
- Gregory HirschMorristown$1.3M
- Steven SussmanLawrenceville$623K
- Geoffrey BowersVoorhees$228K
- Neha DeshpandePlainsboro$206K
- Justin ChuraSwedesboro$193K
- Paula JasionowskiVoorhees$193K
- Peter ChenSewell$191K
- Andrea VentolaFlorham Park$145K
- Kristy PalomaresNew Brunswick$100K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.